These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31669330)

  • 1. Drug-induced liver injury severity and toxicity (DILIst): binary classification of 1279 drugs by human hepatotoxicity.
    Thakkar S; Li T; Liu Z; Wu L; Roberts R; Tong W
    Drug Discov Today; 2020 Jan; 25(1):201-208. PubMed ID: 31669330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
    Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Battery of
    Rathman J; Yang C; Ribeiro JV; Mostrag A; Thakkar S; Tong W; Hobocienski B; Sacher O; Magdziarz T; Bienfait B
    Chem Res Toxicol; 2021 Feb; 34(2):601-615. PubMed ID: 33356149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI).
    Minerali E; Foil DH; Zorn KM; Lane TR; Ekins S
    Mol Pharm; 2020 Jul; 17(7):2628-2637. PubMed ID: 32422053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Detection of Drug-Induced Liver Injury by Integrating Predicted
    Seal S; Williams D; Hosseini-Gerami L; Mahale M; Carpenter AE; Spjuth O; Bender A
    Chem Res Toxicol; 2024 Aug; 37(8):1290-1305. PubMed ID: 38981058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA-approved drug labeling for the study of drug-induced liver injury.
    Chen M; Vijay V; Shi Q; Liu Z; Fang H; Tong W
    Drug Discov Today; 2011 Aug; 16(15-16):697-703. PubMed ID: 21624500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs.
    Hong H; Thakkar S; Chen M; Tong W
    Sci Rep; 2017 Dec; 7(1):17311. PubMed ID: 29229971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs.
    Chen M; Hong H; Fang H; Kelly R; Zhou G; Borlak J; Tong W
    Toxicol Sci; 2013 Nov; 136(1):242-9. PubMed ID: 23997115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
    Aleo MD; Luo Y; Swiss R; Bonin PD; Potter DM; Will Y
    Hepatology; 2014 Sep; 60(3):1015-22. PubMed ID: 24799086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measures of BSEP Inhibition In Vitro Are Not Useful Predictors of DILI.
    Chan R; Benet LZ
    Toxicol Sci; 2018 Apr; 162(2):499-508. PubMed ID: 29272540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury
    Rana P; Aleo MD; Wen X; Kogut S
    Acta Pharm Sin B; 2021 Dec; 11(12):3857-3868. PubMed ID: 35024312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatotoxicity by Drugs: The Most Common Implicated Agents.
    Björnsson ES
    Int J Mol Sci; 2016 Feb; 17(2):224. PubMed ID: 26861310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Models Using Multiple Machine Learning Algorithms for Predicting Drug Hepatotoxicity with the DILIrank Dataset.
    Ancuceanu R; Hovanet MV; Anghel AI; Furtunescu F; Neagu M; Constantin C; Dinu M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32204453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury.
    Chen M; Borlak J; Tong W
    Hepatology; 2013 Jul; 58(1):388-96. PubMed ID: 23258593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified multiparametric assay using HepaRG cells for predicting the degree of drug-induced liver injury risk.
    Tomida T; Okamura H; Yokoi T; Konno Y
    J Appl Toxicol; 2017 Mar; 37(3):382-390. PubMed ID: 27480533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving beyond Binary Predictions of Human Drug-Induced Liver Injury (DILI) toward Contrasting Relative Risk Potential.
    Aleo MD; Shah F; Allen S; Barton HA; Costales C; Lazzaro S; Leung L; Nilson A; Obach RS; Rodrigues AD; Will Y
    Chem Res Toxicol; 2020 Jan; 33(1):223-238. PubMed ID: 31532188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of average molecular weight (AMW) as a useful chemical descriptor to discriminate liver injury-inducing drugs.
    Shimizu Y; Sasaki T; Takeshita JI; Watanabe M; Shizu R; Hosaka T; Yoshinari K
    PLoS One; 2021; 16(6):e0253855. PubMed ID: 34170966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Detection of Drug-Induced Liver Injury by Integrating Predicted
    Seal S; Williams DP; Hosseini-Gerami L; Mahale M; Carpenter AE; Spjuth O; Bender A
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Prediction Models for Drug-Induced Cholestasis, Cirrhosis, Hepatitis, and Steatosis Based on Drug and Drug Metabolite Structures.
    Shin HK; Kang MG; Park D; Park T; Yoon S
    Front Pharmacol; 2020; 11():67. PubMed ID: 32116729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ensemble learning approach for modeling the systems biology of drug-induced injury.
    Aguirre-Plans J; Piñero J; Souza T; Callegaro G; Kunnen SJ; Sanz F; Fernandez-Fuentes N; Furlong LI; Guney E; Oliva B
    Biol Direct; 2021 Jan; 16(1):5. PubMed ID: 33435983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.